Medtech Industry Group
A discussion group open to companies involved in all parts of the advanced medical technology industry, from those serving mainline therapeutic categories such as orthopedics and cardiovascular, through diagnostics, imaging and eHealth to those involved in platform technologies such as biomaterials and regenerative medicine. The forum is also open to companies serving the industry, such as manufacturers, law firms, CROs and distributors.
We want to connect with Development engineering experts. Medical facility development
- To work with the company to improve the design of the structure. Improving the possible work flow within the facility for a range of healthcare services. Keep this within the limitations of the flat-pack design.
- Task to be performed: Co develop a second generation of flat pack hospitals extending the range of medical services provided.
Online partnering opens tomorrow for Medtech Partnering Forum, the only dedicated medical device partnering event in Japan. The event, held in Tokyo May 28–29, 2015, will bring leading life science executives and decision makers to Tokyo to participate in one-to-one partnering meetings with innovative medtech companies. Japan is the largest market for medical devices in Asia (the Japanese spend more on healthcare than China), and the second largest medical device market in the world, behind only the USA. This is your opportunity to get in on the ground floor, to find partners to help develop an innovative technology, and to be part of something potentially transformative. Share your insights on the Japan medtech market here.
Is this the year of the medtech? We’ll have to wait for the next few months to play out, but evidence suggests that 2014 may be on its way to that distinction. Medical Device Business recently outlined three reasons to believe that this year has in fact been a great one for medtechs.
M&A activity has been very strong. Through the first half of the year, the total value of M&As stood at about USD 27.2 billion compared to only USD 19 billion for all of 2013. That trend continued with megadeals agreed upon between Medtronic and Covidien, and between Zimmer and Biomet.
VC money is still tricky but there are exceptions. It continues to be a challenge to pry money from the hands of venture capitalists but that doesn’t mean there haven’t been successes. The most notable: Proteus Digital Health who raised separate rounds of USD 120 million and USD 50 million earlier in the year.
FDA moves faster than a speeding bullet. Well, that may be a bit of an exaggeration but approvals are coming at a faster clip through the first half of this year. For the first six months of 2014, 17 PMAs were approved compared to only nine during that same period the year before.
Should we expect the same to continue for the rest of the year?
You can find the Medical Device Business article here- http://bit.ly/1rIYld0
It seems like the medical device community is seeing a new breakthrough in 3D printing almost every week. That being the case, the FDA has decided they need to provide some additional regulatory clarity on the industry. A public workshop will discuss technological challenges as well as regulatory implications and hopes to gather technical input for evaluating medical devices in the future.
In a recent interview, the FDA’s Steven K. Pollack, Director of the Office of Science & Engineering Labs, explained, “The benefit of 3D printing is that it greatly expands the ability to create devices that are matched to individual patient anatomy. 3D-printing techniques have different technical considerations than standard manufacturing... devices manufactured using this technology may need additional or different testing than is normally required of products manufactured using traditional (or subtractive) techniques.”
The FDA workshop, Additive Manufacturing of Medical Devices, will take place October 8-9.
What are some of the regulatory issues that have your attention?